학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 122건 | 목록
1~20
Academic Journal
In Bioorganic & Medicinal Chemistry 2002 10(1):167-174
Academic Journal
In Tetrahedron 3 March 2001 57(10):1891-1896
Academic Journal
Roy N; Vividion Therapeutics (United States) San Diego United States.; Wyseure T; Vividion Therapeutics (United States) San Diego United States.; Lo IC; Degron Therapeutics SanDiego United States.; Lu J; Vividion Therapeutics (United States) San Diego United States.; Eissler CL; Vividion Therapeutics (United States) San Diego United States.; Bernard SM; Vividion Therapeutics (United States) San Diego United States.; Bok I; Washington University Medical Center St. Louis, Missouri United States.; Snead AN; Vividion Therapeutics (United States) San Diego United States.; Parker A; Vividion Therapeutics (United States) San Diego United States.; Lo UG; Vividion Therapeutics (United States) San Diego United States.; Green JC; Vividion Therapeutics (United States) San Diego United States.; Inloes J; Vividion Therapeutics (United States) San Diego United States.; Jacinto SR; Vividion Therapeutics (United States) San Diego United States.; Kuenzi B; Vividion Therapeutics (United States) San Diego United States.; Pariollaud M; Vividion Therapeutics (United States) San Diego United States.; Negri K; Vividion Therapeutics (United States) San Diego United States.; Le K; Vividion Therapeutics (United States) San Diego United States.; Horning BD; Vividion Therapeutics (United States) San Diego United States.; Ibrahim N; Vividion Therapeutics (United States) San Diego United States.; Grabow S; Vividion Therapeutics (United States) San Diego United States.; Panda H; Washington University in St. Louis United States.; Bhatt DP; Washington University in St. Louis Saint Louis, MO United States.; Wilkerson EM; Washington University in St. Louis Saint Louis, MO United States.; Saeidi S; Washington University in St. Louis United States.; Zolkind P; Washington University in St. Louis Saint Louis, MO United States.; Rush Z; Vividion Therapeutics (United States) San Diego United States.; Williams HN; Vividion Therapeutics United States.; Walton E; Vividion Therapeutics (United States) San Diego United States.; Pastuszka MK; Vividion Therapeutics (United States) San Diego United States.; Sigler JJ; Vividion Therapeutics (United States) San Diego United States.; Tran E; Vividion Therapeutics (United States) San Diego, California United States.; Hee K; sciex United States.; McLaughlin J; Vividion Therapeutics (United States) San Diego United States.; Ambrus-Aikelin G; Genesis Therapeutics United States.; Pollock J; Vividion Therapeutics (United States) San Diego United States.; Abraham RT; Engine Biosciences San Diego, CA United States.; Kinsella TM; Independent researcher United States.; Simon GM; Vividion Therapeutics (United States) San Diego United States.; Major MB; Washington University in St. Louis St. Louis, MO United States.; Weinstein DS; Vividion Therapeutics (United States) San Diego United States.; Patricelli MP; Vividion Therapeutics (United States) San Diego United States.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Baltgalvis KA; Vividion Therapeutics, San Diego, CA, USA.; Lamb KN; Vividion Therapeutics, San Diego, CA, USA.; Symons KT; Vividion Therapeutics, San Diego, CA, USA.; Wu CC; Vividion Therapeutics, San Diego, CA, USA.; Hoffman MA; Vividion Therapeutics, San Diego, CA, USA.; Snead AN; Vividion Therapeutics, San Diego, CA, USA.; Song X; Vividion Therapeutics, San Diego, CA, USA.; Glaza T; Vividion Therapeutics, San Diego, CA, USA.; Kikuchi S; Vividion Therapeutics, San Diego, CA, USA.; Green JC; Vividion Therapeutics, San Diego, CA, USA.; Rogness DC; Vividion Therapeutics, San Diego, CA, USA.; Lam B; Vividion Therapeutics, San Diego, CA, USA.; Rodriguez-Aguirre ME; Vividion Therapeutics, San Diego, CA, USA.; Woody DR; Vividion Therapeutics, San Diego, CA, USA.; Eissler CL; Vividion Therapeutics, San Diego, CA, USA.; Rodiles S; Vividion Therapeutics, San Diego, CA, USA.; Negron SM; Vividion Therapeutics, San Diego, CA, USA.; Bernard SM; Vividion Therapeutics, San Diego, CA, USA.; Tran E; Vividion Therapeutics, San Diego, CA, USA.; Pollock J; Vividion Therapeutics, San Diego, CA, USA.; Tabatabaei A; Vividion Therapeutics, San Diego, CA, USA.; Contreras V; Vividion Therapeutics, San Diego, CA, USA.; Williams HN; Vividion Therapeutics, San Diego, CA, USA.; Pastuszka MK; Vividion Therapeutics, San Diego, CA, USA.; Sigler JJ; Vividion Therapeutics, San Diego, CA, USA.; Pettazzoni P; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Rudolph MG; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Classen M; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Brugger D; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Claiborne C; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Plancher JM; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Cuartas I; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.; Seoane J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.; Burgess LE; Vividion Therapeutics, San Diego, CA, USA.; Abraham RT; Vividion Therapeutics, San Diego, CA, USA.; Odyssey Therapeutics, San Diego, CA, USA.; Weinstein DS; Vividion Therapeutics, San Diego, CA, USA.; Simon GM; Vividion Therapeutics, San Diego, CA, USA.; Patricelli MP; Vividion Therapeutics, San Diego, CA, USA. mattp@vividion.com.; Kinsella TM; Vividion Therapeutics, San Diego, CA, USA. tkinsella71c@gmail.com.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Baltgalvis KA; Vividion Therapeutics, San Diego, CA, USA.; Lamb KN; Vividion Therapeutics, San Diego, CA, USA.; Symons KT; Vividion Therapeutics, San Diego, CA, USA.; Wu CC; Vividion Therapeutics, San Diego, CA, USA.; Hoffman MA; Vividion Therapeutics, San Diego, CA, USA.; Snead AN; Vividion Therapeutics, San Diego, CA, USA.; Song X; Vividion Therapeutics, San Diego, CA, USA.; Glaza T; Vividion Therapeutics, San Diego, CA, USA.; Kikuchi S; Vividion Therapeutics, San Diego, CA, USA.; Green JC; Vividion Therapeutics, San Diego, CA, USA.; Rogness DC; Vividion Therapeutics, San Diego, CA, USA.; Lam B; Vividion Therapeutics, San Diego, CA, USA.; Rodriguez-Aguirre ME; Vividion Therapeutics, San Diego, CA, USA.; Woody DR; Vividion Therapeutics, San Diego, CA, USA.; Eissler CL; Vividion Therapeutics, San Diego, CA, USA.; Rodiles S; Vividion Therapeutics, San Diego, CA, USA.; Negron SM; Vividion Therapeutics, San Diego, CA, USA.; Bernard SM; Vividion Therapeutics, San Diego, CA, USA.; Tran E; Vividion Therapeutics, San Diego, CA, USA.; Pollock J; Vividion Therapeutics, San Diego, CA, USA.; Tabatabaei A; Vividion Therapeutics, San Diego, CA, USA.; Contreras V; Vividion Therapeutics, San Diego, CA, USA.; Williams HN; Vividion Therapeutics, San Diego, CA, USA.; Pastuszka MK; Vividion Therapeutics, San Diego, CA, USA.; Sigler JJ; Vividion Therapeutics, San Diego, CA, USA.; Pettazzoni P; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Rudolph MG; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Classen M; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Brugger D; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Claiborne C; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Plancher JM; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Cuartas I; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.; Seoane J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.; Burgess LE; Vividion Therapeutics, San Diego, CA, USA.; Abraham RT; Vividion Therapeutics, San Diego, CA, USA.; Odyssey Therapeutics, San Diego, CA, USA.; Weinstein DS; Vividion Therapeutics, San Diego, CA, USA.; Simon GM; Vividion Therapeutics, San Diego, CA, USA.; Patricelli MP; Vividion Therapeutics, San Diego, CA, USA. mattp@vividion.com.; Kinsella TM; Vividion Therapeutics, San Diego, CA, USA. tkinsella71c@gmail.com.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Academic Journal
Fruman, David A; Chiu, Honyin; Hopkins, Benjamin D; Bagrodia, Shubha; Cantley, Lewis C; Abraham, Robert T
Cell, vol 170, iss 4
Academic Journal
Park S; Pfizer, La Jolla, CA, USA.; Lyell Immunopharma, South San Francisco, CA, USA.; Pascua E; Pfizer, La Jolla, CA, USA.; Lindquist KC; Pfizer, La Jolla, CA, USA.; Kimberlin C; Pfizer, La Jolla, CA, USA.; Asher Bio, South San Francisco, CA, USA.; Deng X; Pfizer, La Jolla, CA, USA.; Dren Bio, San Carlos, CA, USA.; Mak YSL; Pfizer, La Jolla, CA, USA.; Allogene Therapeutics, South San Francisco, CA, USA.; Melton Z; Pfizer, La Jolla, CA, USA.; Allogene Therapeutics, South San Francisco, CA, USA.; Johnson TO; Pfizer, La Jolla, CA, USA.; Lin R; Pfizer, La Jolla, CA, USA.; Allogene Therapeutics, South San Francisco, CA, USA.; Boldajipour B; Pfizer, La Jolla, CA, USA.; Lyell Immunopharma, South San Francisco, CA, USA.; Abraham RT; Pfizer, La Jolla, CA, USA.; Vividion Therapeutics, San Diego, CA, USA.; Pons J; Pfizer, La Jolla, CA, USA.; ALX Oncology, Burlingame, CA, USA.; Sasu BJ; Pfizer, La Jolla, CA, USA.; Allogene Therapeutics, South San Francisco, CA, USA.; Van Blarcom TJ; Pfizer, La Jolla, CA, USA. tom.vanblarcom@allogene.com.; Allogene Therapeutics, South San Francisco, CA, USA. tom.vanblarcom@allogene.com.; Chaparro-Riggers J; Pfizer, La Jolla, CA, USA. javier.chaparro-riggers@pfizer.com.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Maskey RS; Oncology Research & Development, Pfizer Worldwide Research and Development , Pearl River, NY, USA.; Wang F; Oncology Research & Development, Pfizer Worldwide Research and Development , Pearl River, NY, USA.; Lehman E; Oncology Research & Development, Pfizer Worldwide Research and Development , Pearl River, NY, USA.; Wang Y; Oncology Research & Development, Pfizer Worldwide Research and Development , Pearl River, NY, USA.; Emmanuel N; Oncology Research & Development, Pfizer Worldwide Research and Development , Pearl River, NY, USA.; Zhong W; Oncology Research & Development, Pfizer Worldwide Research and Development , Pearl River, NY, USA.; Jin G; Oncology Research & Development, Pfizer Worldwide Research and Development , Pearl River, NY, USA.; Abraham RT; Oncology Research & Development, Pfizer Worldwide Research and Development , Pearl River, NY, USA.; Arndt KT; Oncology Research & Development, Pfizer Worldwide Research and Development , Pearl River, NY, USA.; Myers JS; Oncology Research & Development, Pfizer Worldwide Research and Development , Pearl River, NY, USA.; Mazurek A; Oncology Research & Development, Pfizer Worldwide Research and Development , Pearl River, NY, USA.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1551-4005 (Electronic) Linking ISSN: 15514005 NLM ISO Abbreviation: Cell Cycle Subsets: MEDLINE
Academic Journal
Arensman MD; Pfizer, Oncology Research & Development, Pearl River, NY, USA.; Yang XS; Pfizer, Oncology Research & Development, Pearl River, NY, USA.; Zhong W; Pfizer, Oncology Research & Development, Pearl River, NY, USA.; Bisulco S; Pfizer, Oncology Research & Development, Pearl River, NY, USA.; Upeslacis E; Pfizer, Oncology Research & Development, Pearl River, NY, USA.; Rosfjord EC; Pfizer, Oncology Research & Development, Pearl River, NY, USA.; Deng S; Pfizer, Oncology Research & Development, San Diego, CA, USA.; Abraham RT; Pfizer, Oncology Research & Development, San Diego, CA, USA.; Eng CH; Pfizer, Oncology Research & Development, Pearl River, NY, USA.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Electronic Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology
Academic Journal
Lehman E; Oncology Research and Development Group, 401 North Middletown Road/PRL-200/4502D, Pfizer Worldwide Research and Development, Pearl River, NY 10965, USA.; Abraham RT; Oncology Research and Development Group, 10646 Science Center Drive/CB4, Pfizer Worldwide Research and Development, San Diego, CA 92121, USA. robert.abraham@pfizer.com.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE
Academic Journal
European Journal of Biochemistry. Mar 01, 2001 268(5):1508-1515
Academic Journal
Alonso, Andres; Rahmouni, Souad; Williams, Scott; van Stipdonk, Marianne; Jaroszewski, Lukasz; Godzik, Adam; Abraham, Robert T; Schoenberger, Stephen P; Mustelin, Tomas
Nature Immunology. 4:44-48
Academic Journal
Lu S; Drug Safety Research and Development, Pfizer Inc., San Diego, CA, United States of America.; Sung T; Drug Safety Research and Development, Pfizer Inc., San Diego, CA, United States of America.; Lin N; iXCells Biotechnologies, San Diego, CA, United States of America.; Abraham RT; Oncology Research Unit, Pfizer Inc., San Diego, CA, United States of America.; Jessen BA; Drug Safety Research and Development, Pfizer Inc., San Diego, CA, United States of America.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Abraham RT; Oncology-Rinat Research and Development Group, Pfizer Worldwide Research and Development, 10646 Science Center Drive/CB4, San Diego, CA 92121, USA. robert.abraham@pfizer.com.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101465400 Publication Model: Electronic Cited Medium: Internet ISSN: 1937-9145 (Electronic) Linking ISSN: 19450877 NLM ISO Abbreviation: Sci Signal Subsets: MEDLINE
Academic Journal
The EMBO Reports. 7(4):425-430
Academic Journal
The EMBO Journal. 23(23):4660-4669
검색 결과 제한하기
제한된 항목
[AR] Abraham, Robert T
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어